Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 374.00
Ask: 384.00
Change: 10.00 (2.70%)
Spread: 10.00 (2.674%)
Open: 382.00
High: 382.00
Low: 380.00
Prev. Close: 370.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

7 Jul 2009 07:00

RNS Number : 2015V
Microgen PLC
07 July 2009
 



microgen

www.microgen.com

 7 July 2009

M icrogen plc

Trading Update

Microgen plc ('Microgen' or 'the Group'provides an update on trading ahead of the Group's Interim Results, for the six months ended 30 June 2009, which are anticipated to be released in late July. 

During the first half of 2009, Microgen Aptitude Solutions Division ("MASD") has seen considerable success. In addition to the multi-million pound contract reported in the April Interim Management Statementthe division is also now engaged on three significant new customer projects :

Major UK Bank : MASD has recently signed a contract for Microgen Accounting Hub and Microgen Aptitude. This project is anticipated to produce revenue in excess of £1 million in the coming year.

US Manufacturer : In parallel with final contract negotiations, MASD is commencing the initial design phase of a project for Microgen Aptitude which is also anticipated to produce revenue in excess of £1 million in the coming year.

Major US Financial Institution : MASD is currently undertaking a significant customer-funded proof-of-concept which may or may not lead to a major contract for Microgen Aptitude and/or Microgen Accounting Hub.

As a result of these projects and additional prospects, the Board anticipates MASD delivering a strong second half of the year. The operating loss for MASD in the first-half has significantly reduced compared to the prior year. Microgen expenses all development costs as incurred and has no R&D capitalisation on its balance sheet. This results in a high correlation between operating income and cash flow for the Group as a whole and, as the revenue increases within MASD, profitability of this division should scale accordingly.

As anticipated, the Group's Billing Services Division and Financial Systems Division have reflected the economic climate but are trading in line with the Board's expectations. These divisions have high recurring revenue and hence remain profitable, high margin businesses with strong cash flow.

Cash at 30 June 2009 was £15.2 million, compared to £14.7 million at 31 December 2008, after repayment of £1.3 million of the loan associated with the freehold property and payment of the final dividend of £1.2 million.

Overall, despite the continuing difficult market environment, the first half of 2009 is anticipated to be in line with the Board's expectations, but, as a result of the strong MASD performance, and subject to contracts being finalised for the two projects noted aboveearnings for the year are anticipated to be ahead of current market expectations.

Contacts

Martyn Ratcliffe, Chairman

01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

Giles Sanderson, Financial Dynamics

Haya Chelhot, Financial Dynamics

020-7831-3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBSGDRXXGGGCL
Date   Source Headline
9th Jun 20157:00 amRNSAcquisition
18th May 20159:58 amRNSResult of AGM
18th May 20157:00 amRNSAGM Trading Update
29th Apr 201512:26 pmRNSHolding(s) in Company
30th Mar 20155:49 pmRNSBlocklisting Interim Review
19th Mar 20157:00 amRNSReturn of Value and Listing of New Ordinary Shares
18th Mar 201511:23 amRNSResults of General Meeting
6th Mar 201512:22 pmRNSHolding(s) in Company
26th Feb 20153:39 pmRNSHolding(s) in Company
25th Feb 20152:26 pmRNS2014 Final Dividend
25th Feb 20157:02 amRNSReturn of Value
25th Feb 20157:01 amRNSPreliminary Results
28th Jan 20152:02 pmRNSHolding(s) in Company
23rd Jan 20151:17 pmRNSHolding(s) in Company
23rd Jan 20157:00 amRNSTrading Update
21st Jan 201512:14 pmRNSDirector Declaration
5th Jan 20157:00 amRNSBlocklisting Interim Review
5th Dec 20147:00 amRNSAcquisition
3rd Nov 20147:00 amRNSTotal Voting Rights
30th Oct 20147:00 amRNSInterim Management Statement
7th Oct 20142:28 pmRNSAdditional Listing
30th Sep 20142:47 pmRNSBlocklisting Interim Review
15th Sep 20145:04 pmRNSHolding(s) in Company
1st Sep 20147:00 amRNSTotal Voting Rights
21st Jul 20147:00 amRNSInterim Results
14th Jul 20143:00 pmRNSNotice of Results
1st Jul 201412:11 pmRNSBlocklisting Interim Review
20th Jun 20148:10 amRNSDirector Declaration
17th Jun 20147:00 amRNSStatement regarding Elektron Technology plc
11th Jun 20149:34 amPRNForm 8 (OPD) Microgen plc
5th Jun 20142:20 pmRNSForm 8.3 - Microgen Plc
5th Jun 201412:13 pmRNSForm 8.3 - Microgen PLC
2nd Jun 20145:33 pmRNSForm 8 (OPD) Microgen plc
2nd Jun 201412:35 pmRNSForm 8.3 - [Microgen Plc]
2nd Jun 201410:50 amRNSTotal Voting Rights
30th May 201410:23 amBUSForm 8.3 - Microgen Plc
29th May 201410:08 amRNSRule 8.3 opening position disclosure
27th May 20142:39 pmPRNForm 8.3 - Microgen plc
27th May 20142:10 pmRNSStatement re Elektron Technology Plc
27th May 201411:44 amRNSForm 8.3 - Microgen Plc
23rd May 20145:22 pmRNSForm 8.3 - Microgen plc
23rd May 201410:22 amRNSForm 8.3 - Microgen Plc
21st May 20143:29 pmRNSForm 8.3 - [Microgen plc]
21st May 20143:04 pmRNSForm 8.3 - Microgen Plc
21st May 20142:13 pmRNSForm 8.3 - MICROGEN PLC
21st May 20141:10 pmRNSForm 8.3 - Microgen Plc
21st May 201411:48 amBUSForm 8.3 - Microgen Plc
21st May 201411:46 amRNSForm 8.3 - [MICROGEN PLC]
21st May 201411:21 amRNSForm 8.3 - MICROGEN ORD GBP0.05
21st May 20149:00 amRNSResponse to Microgen

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.